Skip to content
← All treatment topics

TREATMENT READING

Adrenocortical Carcinoma

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

27 sections
  1. Treatment of Stage I Adrenocortical Carcinoma
  2. Treatment Options for Stage I Adrenocortical Carcinoma (ACC)
  3. Treatment of Stage II Adrenocortical Carcinoma
  4. Treatment Options for Stage II Adrenocortical Carcinoma (ACC)
  5. Treatment of Stage III Adrenocortical Carcinoma
  6. Treatment Options for Stage III Adrenocortical Carcinoma (ACC)
  7. Treatment of Stage IV Adrenocortical Carcinoma
  8. Treatment Options for Stage IV Adrenocortical Carcinoma (ACC)
  9. Treatment of Recurrent Adrenocortical Carcinoma
  10. Adrenocortical Carcinoma Treatment
  11. Treatment options for adrenocortical carcinoma
  12. Surgery
  13. Radiation therapy
  14. Chemotherapy
  15. New treatments being tested in clinical trials
  16. Immunotherapy
  17. Targeted therapy
  18. Side effects of treatment
  19. Clinical trials
  20. Patients can enter clinical trials before, during, or after starting their cancer treatment
  21. Follow-up care
  22. Adrenocortical Carcinoma Treatment by Stage
  23. Treatment of stage I adrenocortical carcinoma
  24. Treatment of stage II adrenocortical carcinoma
  25. Treatment of stage III adrenocortical carcinoma
  26. Treatment of stage IV adrenocortical carcinoma
  27. Treatment of recurrent adrenocortical carcinoma

Health professional

Treatment of Stage I Adrenocortical Carcinoma

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Health professional · Treatment of Stage I Adrenocortical Carcinoma

Treatment Options for Stage I Adrenocortical Carcinoma (ACC)

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Treatment options for stage I ACC include:

Sources: stage I ACC

Complete surgical removal of the tumor is the treatment of choice for patients with stage I ACC. The long-term survival of patients with nonfunctioning tumors is comparable with that of patients with functioning tumors. The removal of regional lymph nodes that are not clinically enlarged is not indicated.

Adjuvant mitotane (under clinical evaluation).Adjuvant mitotane has shown some progression-free or disease-free survival advantage, but no overall survival advantage.[1-3]

Sources: 1 · 3

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional

Treatment of Stage II Adrenocortical Carcinoma

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Health professional · Treatment of Stage II Adrenocortical Carcinoma

Treatment Options for Stage II Adrenocortical Carcinoma (ACC)

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Treatment options for stage II ACC include:

Sources: stage II ACC

Complete surgical removal of the tumor is the treatment of choice for patients with stage II ACC. The long-term survival of patients with nonfunctioning tumors is comparable with that of patients with functioning tumors. The removal of regional lymph nodes that are not clinically enlarged is not indicated.

Adjuvant mitotane (under clinical evaluation).Adjuvant mitotane has shown some progression-free or disease-free survival advantage, no overall survival advantage.[1-3]

Sources: 1 · 3

Health professional

Treatment of Stage III Adrenocortical Carcinoma

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Health professional · Treatment of Stage III Adrenocortical Carcinoma

Treatment Options for Stage III Adrenocortical Carcinoma (ACC)

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Treatment options for stage III ACC include:

Sources: stage III ACC

Complete surgical removal of the tumor, with or without regional lymph node dissection, is the treatment of choice for patients with stage III ACC. The treatment of patients who have tumors with local invasion, but without clinically enlarged regional lymph nodes, is complete surgical removal, as for stage I and stage II tumors. For those with enlarged regional lymph nodes, a lymph node dissection should be included in the procedure. These patients are at high risk of disease recurrence and should consider enrolling in a clinical trial.

Radiation therapy (approximately 50–70 Gy over a period of 4 weeks) may be given to patients with localized but unresectable tumors (under clinical evaluation).[1]

Sources: 1

Chemotherapy with mitotane in doses as high as 10 to 12 g/day to achieve a blood level of 14 to 20 mg/L should be considered for patients unable to undergo complete resection (under clinical evaluation). This adrenolytic drug produces useful clinical responses in about 20% to 30% of patients with measurable tumor burden.[2,3]The role of mitotane as adjuvant therapy after complete tumor resection is still unclear but should be discussed with the patient. For patients who undergo a complete resection, the role of adjuvant mitotane and radiation therapy is the same as for patients with stage I and stage II ACC.

Sources: 2 · 3

Chemotherapy with mitotane plus streptozotocin or mitotane plus etoposide, doxorubicin, and cisplatin may be effective and has been compared in a phase III clinical trial (NCT00924144) (under clinical evaluation).[2]

Sources: NCT00924144 · 2

Many patients with functioning tumors who receive treatment experience reduced hormone production. In patients with increased hormone production, antisteroidogenic drugs, such as ketoconazole and metyrapone, and steroid receptor antagonists, such as spironolactone and mifepristone, should be considered.

Clinical trials are appropriate for newly diagnosed patients.

Health professional

Treatment of Stage IV Adrenocortical Carcinoma

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Health professional · Treatment of Stage IV Adrenocortical Carcinoma

Treatment Options for Stage IV Adrenocortical Carcinoma (ACC)

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Treatment options for stage IV ACC include:

Sources: stage IV ACC

Chemotherapy with mitotane.

Chemotherapy with mitotane plus streptozotocin or mitotane plus etoposide, doxorubicin, and cisplatin, as evidenced by the NCT00924144 phase III clinical trial.[1]

Sources: NCT00924144 · 1

Radiation therapy to bone metastases.

Surgical removal of localized metastases, particularly for tumors that are functioning.

Insulin-like growth factor 1 receptor–inhibitors (under clinical evaluation).

Gossypol (under clinical evaluation).

Temporary palliation of disseminated ACC can sometimes be achieved with the chemotherapeutic agent mitotane. Although measurable partial remissions are unusual and are reported in only 20% to 30% of patients, palliation of hormone symptoms is commonly observed. Prolonged treatment with mitotane, however, is often limited by gastrointestinal and neurological toxicity. Local recurrences and selected sites of metastatic disease can sometimes be palliated surgically or with radiation therapy.[1,2]

Sources: 1 · 2

Two other cytotoxic chemotherapy regimens may be effective and have been compared in a phase III clinical trial:[1]

Sources: 1

Streptozotocin plus mitotane.

Etoposide, doxorubicin, and cisplatin plus mitotane.

Clinical trials of other chemotherapy regimens are ongoing.

Many patients with functioning tumors who receive treatment experience reduced hormone production. In patients with increased hormone production, antisteroidogenic drugs, such as ketoconazole and metyrapone, and steroid receptor antagonists, such as spironolactone and mifepristone, should be considered.

Clinical trials, including phase I and II trials of newer chemotherapeutic and biological agents, are appropriate and should be considered.

Health professional

Treatment of Recurrent Adrenocortical Carcinoma

Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: December 13, 2024. Captured 2026-09-09.

Deciding to treat patients with recurrent adrenocortical carcinoma (ACC), and what treatment to use, depends on many factors, including previous treatment, site of recurrence, and individual patient considerations. Local recurrence and selected sites of metastatic disease can sometimes be palliated by surgery or radiation therapy. Although recurrent ACC is not considered curable, palliation of hormonal symptoms and occasional 5-year survivals can be achieved.[1] However, substantial morbidity is associated with resection of recurrent tumors.

Sources: 1

Clinical trials, including phase I and II trials of newer chemotherapeutic and biological agents, are appropriate and should be considered.

For patients

Adrenocortical Carcinoma Treatment

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Different types of treatments are available for patients with adrenocortical carcinoma. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

Sources: clinical trials · research study

For patients · Adrenocortical Carcinoma Treatment

Treatment options for adrenocortical carcinoma

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Treatment options for adrenocortical carcinoma

The following types of treatment are used:

For patients · Adrenocortical Carcinoma Treatment / Treatment options for adrenocortical carcinoma

Surgery

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Surgery to remove the adrenal gland (adrenalectomy) is often used to treat adrenocortical carcinoma. Sometimes surgery is done to remove the nearby lymph nodes and other tissue where the cancer has spread.

Sources: Surgery · adrenal gland · adrenalectomy · lymph nodes · tissue

For patients · Adrenocortical Carcinoma Treatment / Treatment options for adrenocortical carcinoma

Radiation therapy

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:

Sources: Radiation therapy · x-rays · radiation · cells

External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.

Sources: External radiation therapy

Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.

Sources: Internal radiation therapy · radioactive · seeds · catheters

The way the radiation therapy is given depends on the type and stage of the cancer being treated.

Sources: stage

For patients · Adrenocortical Carcinoma Treatment / Treatment options for adrenocortical carcinoma

Chemotherapy

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Combination chemotherapy is treatment using more than one anticancer drug. The way the chemotherapy is given depends on the type and stage of the cancer being treated.

Sources: Chemotherapy · drugs · injected · vein · systemic chemotherapy · cerebrospinal fluid · organ · cavity · abdomen · Combination chemotherapy

For patients · Adrenocortical Carcinoma Treatment

New treatments being tested in clinical trials

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

New treatments being tested in clinical trials

This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.

Sources: NCI website

For patients · Adrenocortical Carcinoma Treatment / New treatments being tested in clinical trials

Immunotherapy

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Immunotherapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer.

Sources: Immunotherapy · immune system

For patients · Adrenocortical Carcinoma Treatment / New treatments being tested in clinical trials

Targeted therapy

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells.

Sources: Targeted therapy

For patients · Adrenocortical Carcinoma Treatment

Side effects of treatment

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Side effects of treatment

Treatment for adrenocortical carcinoma may cause side effects. For information about side effects caused by treatment for cancer, visit our Side Effects page.

Sources: side effects · Side Effects

For patients · Adrenocortical Carcinoma Treatment

Clinical trials

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Clinical trials

For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.

Sources: clinical trial · standard treatment

Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.

Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.

For patients · Adrenocortical Carcinoma Treatment / Clinical trials

Patients can enter clinical trials before, during, or after starting their cancer treatment

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.

Clinical trials are taking place in many parts of the country. Find clinical trials for adrenocortical carcinoma at Treatment Clinical Trials for Adrenal Cortex Cancer. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.

Sources: Treatment Clinical Trials for Adrenal Cortex Cancer · ClinicalTrials.gov

For patients · Adrenocortical Carcinoma Treatment

Follow-up care

Source: Adrenocortical Carcinoma Treatment, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Follow-up care

As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.

Sources: diagnose · stage

Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).

For patients

Adrenocortical Carcinoma Treatment by Stage

Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Stage is an important factor in deciding the best treatment for adrenocortical carcinoma. Other factors, such as your preferences and overall health, are also important.

For some people, taking part in a clinical trial may be an option. Clinical trials of new cancer drugs or treatment combinations may be available. Learn more about clinical trials, including how to find and join a trial, at Cancer Clinical Trial Information for Patients and Caregivers.

Sources: Cancer Clinical Trial Information for Patients and Caregivers

Learn more about the treatments listed below at Adrenocortical Carcinoma Treatment.

Sources: Adrenocortical Carcinoma Treatment

For patients · Adrenocortical Carcinoma Treatment by Stage

Treatment of stage I adrenocortical carcinoma

Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Treatment of stage I adrenocortical carcinoma

Treatment of stage I adrenocortical carcinoma may include:

Sources: stage I adrenocortical carcinoma

Surgery (adrenalectomy). Nearby lymph nodes may also be removed if they are larger than normal.

Sources: Surgery · adrenalectomy · lymph nodes

A clinical trial of a new treatment.

Sources: clinical trial

For patients · Adrenocortical Carcinoma Treatment by Stage

Treatment of stage II adrenocortical carcinoma

Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Treatment of stage II adrenocortical carcinoma

Treatment of stage II adrenocortical carcinoma may include:

Sources: stage II adrenocortical carcinoma

Surgery (adrenalectomy). Nearby lymph nodes may also be removed if they are larger than normal.

A clinical trial of a new treatment.

For patients · Adrenocortical Carcinoma Treatment by Stage

Treatment of stage III adrenocortical carcinoma

Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Treatment of stage III adrenocortical carcinoma

Treatment of stage III adrenocortical carcinoma may include:

Sources: stage III adrenocortical carcinoma

Surgery (adrenalectomy). Nearby lymph nodes may also be removed if they are larger than normal.

A clinical trial of radiation therapy.

Sources: radiation therapy

A clinical trial of a new treatment.

For patients · Adrenocortical Carcinoma Treatment by Stage

Treatment of stage IV adrenocortical carcinoma

Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Treatment of stage IV adrenocortical carcinoma

Treatment of stage IV adrenocortical carcinoma may include the following as palliative therapy to relieve symptoms and improve the quality of life:

Sources: stage IV adrenocortical carcinoma · quality of life

Chemotherapy or combination chemotherapy.

Sources: Chemotherapy · combination chemotherapy

Radiation therapy to bones or other sites where cancer has spread.

Surgery to remove cancer that has spread to tissues near the adrenal cortex.

Sources: tissues · adrenal cortex

A clinical trial of chemotherapy, immunotherapy, or targeted therapy.

Sources: immunotherapy · targeted therapy

For patients · Adrenocortical Carcinoma Treatment by Stage

Treatment of recurrent adrenocortical carcinoma

Source: Adrenocortical Carcinoma Treatment by Stage, National Cancer Institute.

Source updated: February 14, 2025. Captured 2026-09-09.

Treatment of recurrent adrenocortical carcinoma

Treatment of recurrent adrenocortical carcinoma may include the following as palliative therapy to relieve symptoms and improve the quality of life:

Sources: recurrent · palliative therapy · symptoms

Surgery.

Radiation therapy.

A clinical trial of chemotherapy or immunotherapy.

Studies

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

NCT00094497 · COMPLETED · phase3

Carcinoma, Adrenal Cortical

ClinicalTrials.gov record

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

NCT02804750 · COMPLETED · phase2

Cushing's Syndrome

ClinicalTrials.gov record

Disease and treatment settings

Adrenocortical Carcinoma

Disease and treatment setting

Adrenocortical Carcinoma

recurrent Adrenocortical Carcinoma

Disease and treatment setting

Treatment of Recurrent Adrenocortical Carcinoma

Stage I Adrenocortical Carcinoma

Disease and treatment setting

Treatment of Stage I Adrenocortical Carcinoma

Stage II Adrenocortical Carcinoma

Disease and treatment setting

Treatment of Stage II Adrenocortical Carcinoma

Stage III Adrenocortical Carcinoma

Disease and treatment setting

Treatment of Stage III Adrenocortical Carcinoma

Stage IV Adrenocortical Carcinoma

Disease and treatment setting

Treatment of Stage IV Adrenocortical Carcinoma

Drug labels

CORTEF

Label date 2025-02-17

INDICATIONS AND USAGE CORTEF Tablets are indicated in the following conditions. 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in...

DailyMed label

Cortrosyn

Label date 2024-04-12

INDICATIONS AND USAGE CORTROSYN ® (cosyntropin) for Injection is intended for use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. Because of its rapid effect on the adrenal cortex it may...

DailyMed label

Hydrocortisone

Label date 2026-05-25

INDICATIONS AND USAGE Hydrocortisone tablets are indicated in the following conditions. 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be...

DailyMed label

Hydrocortisone

Label date 2022-10-12

INDICATIONS AND USAGE Hydrocortisone tablets are indicated in the following conditions. 1. Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be...

DailyMed label

Lysodren

Label date 2025-10-08

LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC). LYSODREN is an adrenal cytotoxic agent indicated for the treatment of patients with inoperable, functional...

DailyMed label

Lysodren

Label date 2026-03-03

LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC). LYSODREN is an adrenal cytotoxic agent indicated for the treatment of patients with inoperable, functional...

DailyMed label

PrednisoLONE Sodium Phosphate

Label date 2026-06-25

INDICATIONS AND USAGE Prednisolone Sodium Phosphate Oral Solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional...

DailyMed label

Prednisolone Sodium Phosphate

Label date 2024-09-23

INDICATIONS AND USAGE Prednisolone Sodium Phosphate Oral Solution is indicated in the following conditions: 1. Allergic States Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional...

DailyMed label